Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 14 studies | 23% ± 8% | |
| type I pneumocyte | 11 studies | 36% ± 9% | |
| epithelial cell | 11 studies | 30% ± 14% | |
| type II pneumocyte | 8 studies | 26% ± 12% | |
| goblet cell | 7 studies | 28% ± 8% | |
| mesothelial cell | 7 studies | 32% ± 13% | |
| secretory cell | 5 studies | 23% ± 6% | |
| basal cell | 5 studies | 30% ± 13% | |
| squamous epithelial cell | 4 studies | 35% ± 18% | |
| club cell | 3 studies | 21% ± 4% | |
| dendritic cell | 3 studies | 22% ± 1% | |
| brush cell | 3 studies | 29% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 2786.97 | 328 / 328 | 99% | 120.01 | 176 / 178 |
| kidney | 100% | 6363.29 | 89 / 89 | 97% | 65.40 | 876 / 901 |
| liver | 100% | 3535.38 | 226 / 226 | 97% | 74.41 | 393 / 406 |
| lung | 100% | 3577.49 | 576 / 578 | 97% | 63.66 | 1116 / 1155 |
| prostate | 93% | 3314.21 | 228 / 245 | 99% | 103.97 | 498 / 502 |
| thymus | 100% | 1906.46 | 652 / 653 | 90% | 30.87 | 547 / 605 |
| stomach | 78% | 3296.70 | 281 / 359 | 98% | 74.52 | 279 / 286 |
| breast | 66% | 1082.95 | 305 / 459 | 90% | 45.47 | 1010 / 1118 |
| intestine | 56% | 2260.73 | 537 / 966 | 99% | 91.07 | 521 / 527 |
| esophagus | 60% | 1328.83 | 863 / 1445 | 95% | 45.37 | 173 / 183 |
| uterus | 55% | 656.15 | 94 / 170 | 96% | 76.01 | 442 / 459 |
| ovary | 52% | 364.31 | 94 / 180 | 99% | 97.74 | 426 / 430 |
| bladder | 52% | 1260.29 | 11 / 21 | 97% | 87.54 | 488 / 504 |
| skin | 75% | 2715.96 | 1360 / 1809 | 55% | 12.14 | 259 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 46.69 | 29 / 29 |
| spleen | 100% | 1357.08 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 240.96 | 1 / 1 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 52.39 | 43 / 45 |
| peripheral blood | 89% | 1116.49 | 827 / 929 | 0% | 0 | 0 / 0 |
| brain | 78% | 1346.69 | 2064 / 2642 | 6% | 2.88 | 40 / 705 |
| adrenal gland | 36% | 196.04 | 92 / 258 | 33% | 7.83 | 77 / 230 |
| adipose | 49% | 606.24 | 586 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 21% | 128.06 | 277 / 1335 | 0% | 0 | 0 / 0 |
| heart | 9% | 53.83 | 80 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.73 | 4 / 80 |
| muscle | 0% | 1.92 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0006915 | Biological process | apoptotic process |
| GO_0034451 | Cellular component | centriolar satellite |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RASSF7 |
| Protein name | Ras association domain-containing protein 7 (HRAS1-related cluster protein 1) Ras association domain family member 7 (Ras association domain-containing protein 7) Ras association domain-containing protein 7 Ras association domain family member 7 |
| Synonyms | HRC1 C11orf13 |
| Description | FUNCTION: Negatively regulates stress-induced JNK activation and apoptosis by promoting MAP2K7 phosphorylation and inhibiting its ability to activate JNK. Following prolonged stress, anti-apoptotic effect stops because of degradation of RASSF7 protein via the ubiquitin-proteasome pathway. Required for the activation of AURKB and chromosomal congression during mitosis where it stimulates microtubule polymerization. . |
| Accessions | ENST00000631421.1 ENST00000633903.1 ENST00000531112.1 A0A0J9YYE4 A0A0G2JLR5 ENST00000528736.1 ENST00000620201.4 ENST00000622905.2 ENST00000454668.2 [Q02833-3] F8W7Q0 ENST00000397582.7 [Q02833-2] ENST00000622100.4 E9PM39 ENST00000431809.5 [Q02833-2] Q02833 ENST00000414138.6 ENST00000397583.8 [Q02833-1] ENST00000632673.1 A0A0G2JMW4 ENST00000632833.1 H0YEI0 |